June 24, 2024

Uncategorized

New Releases from NCBI BookshelfRavulizumab (Ultomiris): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with anti–aquaporin 4 (AQP4) antibody–positive neuromyelitis optica spectrum disorder (NMOSD) [Internet].​Ravulizumab (Ultomiris): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with anti–aquaporin 4 (AQP4) antibody–positive neuromyelitis optica spectrum disorder (NMOSD) [Internet].

CADTH recommends that Ultomiris be reimbursed by public drug plans for the treatment of neuromyelitis optica spectrum disorder (NMOSD) if […]

Uncategorized

New Releases from NCBI BookshelfTesting Whether a Referral to a Telehealth Program Helps African-American and Hispanic Adults with COPD Transition from Hospital to Home [Internet].​Testing Whether a Referral to a Telehealth Program Helps African-American and Hispanic Adults with COPD Transition from Hospital to Home [Internet].

Chronic obstructive pulmonary disease (COPD) is a leading cause of hospitalization in the United States. African American and Hispanic patients

Scroll to Top